BG62197B1 - Антимигренно средство за интраназално приложение - Google Patents

Антимигренно средство за интраназално приложение Download PDF

Info

Publication number
BG62197B1
BG62197B1 BG100889A BG10088996A BG62197B1 BG 62197 B1 BG62197 B1 BG 62197B1 BG 100889 A BG100889 A BG 100889A BG 10088996 A BG10088996 A BG 10088996A BG 62197 B1 BG62197 B1 BG 62197B1
Authority
BG
Bulgaria
Prior art keywords
chitosan
agent
pharmaceutically acceptable
agent according
administration
Prior art date
Application number
BG100889A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG100889A (en
Inventor
Marc K. Francois
Roger C. Embrechts
Lisbeth Illum
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of BG100889A publication Critical patent/BG100889A/xx
Publication of BG62197B1 publication Critical patent/BG62197B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG100889A 1994-04-13 1996-10-08 Антимигренно средство за интраназално приложение BG62197B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94200998 1994-04-13
PCT/EP1995/001302 WO1995028158A1 (en) 1994-04-13 1995-04-10 Intranasal antimigraine composition

Publications (2)

Publication Number Publication Date
BG100889A BG100889A (en) 1997-07-31
BG62197B1 true BG62197B1 (bg) 1999-05-31

Family

ID=8216793

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100889A BG62197B1 (bg) 1994-04-13 1996-10-08 Антимигренно средство за интраназално приложение

Country Status (23)

Country Link
EP (1) EP0755253B1 (xx)
JP (1) JP2921988B2 (xx)
KR (1) KR100219952B1 (xx)
CN (1) CN1146151A (xx)
AT (1) ATE194915T1 (xx)
AU (1) AU684360B2 (xx)
BG (1) BG62197B1 (xx)
BR (1) BR9507369A (xx)
CA (1) CA2184822C (xx)
CZ (1) CZ286610B6 (xx)
DE (1) DE69518149T2 (xx)
FI (1) FI118295B (xx)
HR (1) HRP950149A2 (xx)
HU (1) HU219495B (xx)
IL (1) IL113341A (xx)
NO (1) NO310276B1 (xx)
NZ (1) NZ284454A (xx)
PL (1) PL179761B1 (xx)
RO (1) RO115414B1 (xx)
SI (1) SI9500121A (xx)
SK (1) SK129896A3 (xx)
WO (1) WO1995028158A1 (xx)
ZA (1) ZA953038B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9403905D0 (sv) * 1994-11-14 1994-11-14 Astra Ab New formulations
KR970032844A (ko) * 1995-12-29 1997-07-22 김준웅 지속성 경비투여제제
UA72189C2 (uk) * 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
GB2378383A (en) * 2001-06-06 2003-02-12 Gursharan Moonga Nasal delivery of pharmaceutical compositions in powder form
GB0328186D0 (en) 2003-12-05 2004-01-07 West Pharm Serv Drug Res Ltd Intranasal compositions
US7968122B2 (en) 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946870A (en) * 1986-06-06 1990-08-07 Union Carbide Chemicals And Plastics Company Inc. Delivery systems for pharmaceutical or therapeutic actives
GB8904370D0 (en) * 1989-02-25 1989-04-12 Cosmas Damian Ltd Liquid delivery compositions
SI9300097B (en) * 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
JPH0656675A (ja) * 1992-08-07 1994-03-01 Nippon Soda Co Ltd 家畜の乳房炎予防剤

Also Published As

Publication number Publication date
ATE194915T1 (de) 2000-08-15
CZ292096A3 (en) 1997-02-12
HU9602806D0 (en) 1996-11-28
AU2305495A (en) 1995-11-10
KR100219952B1 (ko) 1999-09-01
JP2921988B2 (ja) 1999-07-19
CN1146151A (zh) 1997-03-26
HU219495B (hu) 2001-04-28
IL113341A0 (en) 1995-07-31
RO115414B1 (ro) 2000-02-28
FI964095A (fi) 1996-10-11
FI118295B (fi) 2007-09-28
HRP950149A2 (en) 1997-06-30
HUT75939A (en) 1997-05-28
NZ284454A (en) 1997-12-19
EP0755253B1 (en) 2000-07-26
BR9507369A (pt) 1997-09-23
DE69518149D1 (de) 2000-08-31
CZ286610B6 (cs) 2000-05-17
AU684360B2 (en) 1997-12-11
SK129896A3 (en) 1997-05-07
CA2184822A1 (en) 1995-10-26
ZA953038B (en) 1996-10-14
IL113341A (en) 2000-08-31
EP0755253A1 (en) 1997-01-29
NO310276B1 (no) 2001-06-18
FI964095A0 (fi) 1996-10-11
CA2184822C (en) 2000-12-19
BG100889A (en) 1997-07-31
SI9500121A (en) 1995-10-31
PL316756A1 (en) 1997-02-03
NO964333D0 (no) 1996-10-11
PL179761B1 (pl) 2000-10-31
DE69518149T2 (de) 2001-03-22
NO964333L (no) 1996-10-11
WO1995028158A1 (en) 1995-10-26
JPH09505606A (ja) 1997-06-03

Similar Documents

Publication Publication Date Title
US11918655B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
RU2762725C2 (ru) Композиции, содержащие триптановые соединения
JP2003501468A (ja) アポモルヒネの経鼻送達
JP2003501467A (ja) 鼻内モルヒネを含む医薬用製剤および方法
EA036520B1 (ru) Ингаляционные и назальные бензодиазепины
US6054462A (en) Intranasal antimigraine compositions
BG62197B1 (bg) Антимигренно средство за интраназално приложение
WO2001035926A2 (en) An improved pharmaceutical composition for treating male erectile dysfunction
US7576133B2 (en) Methods and compositions for nasal administration of modafinil
AU2021254650B2 (en) Intranasal epinephrine formulations and methods for the treatment of disease
JP5845183B2 (ja) トリプタン化合物を含む製剤
FR2680106A1 (fr) Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
JPH01160916A (ja) ドーパミン経鼻投与製剤
JP2002536401A (ja) メタミゾール含有起泡性医薬組成物
EP0323762B1 (fr) Nouvelles compositions anti-tussives et leur procédé d'obtention
HU191512B (en) Process for production of dosed through the nose medical preparatives containing ergot-alcaloids